News
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
Aurora Cannabis posted mixed Q1 FY2026 results, facing sales pressure, covenant issues, and looming German regulatory risks.
If you invested in Canadian cannabis stocks just after legalization in 2018, at the height of investor fervor, you are likely ...
U.S. President Donald Trump’s administration is looking to reclassify marijuana as a less dangerous drug, a shift that could ...
Shares of major cannabis companies are trading higher Monday morning. The stocks are soaring following a WSJ report that ...
Greetings and welcome to Aurora Cannabis Incorporated Fiscal First Quarter 2026 Results Conference Call all participants will ...
Even a skeptic will be forced to admit that Aurora Cannabis seems to be experiencing mounting momentum. The cannabis company's net revenue jumped 30% year over year, to 63.4 million in Canadian ...
Potency Cultivars, Expanding Patient Choice in Australia EDMONTON, ALBERTA, Aug. 12, 2025 /CNW/ – Aurora Cannabis Inc. (NASDAQ: ACB) ...
The Aurora City Council on Monday night gave preliminary approval, by an 8-2 vote, to cannabis delivery in Colorado’s third-largest city.
Despite reporting better-than-expected revenue for Q1 fiscal 2026, Aurora Cannabis (NASDAQ:ACB) traded ~9% lower after the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback